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Abstract 
Antimicrobial resistance: what is the public health sector doing to address this increasing threat 
to the health of the entire world?  This is a global threat, not one that impacts just the poor or 
underdeveloped nations. There appears to be more public recognition of the impact on the public 
health community, but the question is; has it been validated? Will funding be made available? 
What progress has been made for prevention and surveillance? Are we all talk and no action? 
The Centers for Disease Control and Prevention (CDC) has defined the top ten greatest 
achievements of public heath over the past century. In that list is control of communicable 
diseases, which includes the discovery, introduction and utilization of antimicrobial 
agents (Centers for Disease Control and Prevention (CDC), 2011). It is currently accepted that 
the most significant impact on the increase of human life expectancy can be attributed to Public 
Health practice and its achievements. Despite this, funding for public health practice and 
preventative measures is meager at best. Currently, fewer than two percent of health care dollars 
are utilized for Public Health Protection programs and measures.  
In the early 1900s the principle causes of death were primarily infectious diseases. As we 
developed preventative measures, medical treatments and experienced decreased incidence, these 
causes plummeted down the list. Life expectancy increased substantially.  However, we are again 
faced with the threat of increasing impact of infectious diseases on morbidity and human 
mortality.  More microbes are evolving and developing resistance to the defenses that we have 
built against them.   
An overview of current public health initiatives as well as the analysis of antimicrobial 
stewardship programs and their role in prevention and integration into public health leadership 
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will be reviewed and surmised in this report. In addition recommendations for further action will 
be discussed based on best practices determined in the current literature review.  
Introduction  
Antimicrobial resistance is not prejudicial or discriminatory in nature. It affects and impacts 
people irrespective of financial, social, power or educational status. It is all encompassing and, 
therefore, a public health threat! Although programs have been put into place for the prevention 
and control of antimicrobial resistance,  universal governance and guidance would be more 
prudent to assure that best practices are being employed nationally and globally. Public health 
departments and leaders would be the most skilled and appropriate for such an endeavor.  
Within the Twentieth century, public health was responsible for an increase in life expectancy of 
approximately 25 years in the United States (US).  The CDC defines public health as: “the active 
protection of our nation′s health and safety, credible information to enhance health decisions, and 
partnerships with local minorities and organizations to promote good health” (Centers for 
Disease Control and Prevention (CDC), 2011).  One of public health‟s most significant 
contributions in infectious disease mortality reduction occurred with the advent of antibiotics. 
During this era, the discovery, development and support of extensive use of antibiotics, in 
conjunction with sanitation, hygiene and vaccination lead to a significant shift in the most 
prevalent causes of death (Centers for Disease Control and Prevention (CDC), 1999).  In 1900 
the leading causes of death were attributed to three infectious diseases: Tuberculosis, pneumonia, 
and diarrheal disease. Together they accounted for over one-third of the mortality in the United 
States. In comparison during 1997, infectious diseases were responsible for only four and a half 
percent of US mortality.  This shift occurred shortly after the 1940s when penicillin was first 
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introduced to the public and accepted among the medical community (Centers for Disease 
Control and Prevention (CDC), 2011). 
Despite the immediate and universal acceptance of antibiotics as amazing treatments of disease, 
it was not long after their introduction that microorganisms began to develop resistance, slowly 
increasing their threat to human life again (Davies, 1997). Over the years resistance has become 
more prevalent, and the successful introductions and use of new antimicrobials has decreased. 
We are now facing a time referred to as the “Post antibiotic Era” when antimicrobial resistance 
needs to be considered a public health emergency (Tenover & Hughes, 1996)!  
Antimicrobial resistance is a multifaceted issue with several contributory causes. Resistance has 
primarily been attributed to the ability of microbes to adapt to their surrounding environment. 
Some data suggest that microbes may have already been preprogrammed for mutations, resulting 
in resistance long before the introduction of antimicrobials (Davies, 1997). In conjunction with 
microbes‟ unique adaptive abilities, human behaviors have aided in the development of 
antimicrobial resistance, and have hastened the process over the years beyond what might have 
occurred in a natural setting.  The uses - and more specifically - misuses of antimicrobials have 
been a major contributor to the resistance of microbes to many antimicrobials in use today.  
Unfortunately, improper use of antimicrobials is fairly common in both the hospital and the 
community setting.  With that, there is the added misfortune of fewer antimicrobials coming to 
market each year (Cohen, 1992; Craig et al., 1978; Hecker, Aron, Patel, Lehmann, & Donskey, 
2003a; Hecker, Aron, Patel, Lehmann, & Donskey, 2003b; Sunenshine, Liedtke, Jernigan, 
Strausbaugh, & Infectious Diseases Society of America Emerging Infections Network, 2004). 
This has lead to an increase in mortality from what we now know as “super-bugs”. “Super bugs” 
have the ability to infect all walks of human life, not just those who are considered immuno-
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suppressed.  As incidence and prevalence increase across nations, we turn a corner heading back 
toward the days of the 1900s. 
While the above realities have been recognized by many in the medical community, government 
and public health leadership, no direction as to who should take charge has been identified and 
what each person‟s role is. Slowly, endeavors are being launched in a war against resistance. The 
hope is that it will not be too late. 
Public Health Policy 
“Law is foundational to U.S. public health practice. Laws establish and delineate the missions of 
public health agencies, authorize and delimit public health functions, and appropriate essential 
funds,” wrote Goodman and colleagues (2006, p. 29).  In 2011, the Institute of Medicine (IOM) 
published a report titled For the Public‟s Health: Revitalizing Law and Policy to Meet New 
Challenges. The IOM put together a committee to review three topics pertaining to public health: 
measurement, the law and funding. This task was at the request of the Robert Wood Johnson 
Foundation in 2009. For the purpose of this paper, current challenges and past successes of 
public health policy will be reviewed to demonstrate the challenges that are faced by the public 
health sector as well as identify successes and strengths within previous and current actions 
(Goodman et al., 2006; IOM (Institute of Medicine), 2011). 
Most current public health laws are outdated. They were created in the late 19
th
 and early 20
th
 
century and many of these statutes have not been updated in decades. In their time, they were 
backed by scientific evidence of that period.  However the progression of determinants of health 
has continued to evolve since their adoption. In addition, many were created in the midst of a 
public health crisis or outbreak at the time, and are not reflective of our current circumstances. 
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This has resulted in fragmented and duplicative laws that are confusing, at the very least, to enact 
in today‟s day (IOM (Institute of Medicine), 2011; Meier, Hodge, & Gebbie, 2009).  
Another consideration is the establishment of statutes enacted by other areas of government 
which have created unintended consequences. Subsidies paid to the agricultural communities led 
to the introduction of artificial sweeteners, creating nutrition-poor foods. Educational campaigns 
and the national education policy have created a stressed schooling system wherein the physical 
education of our youth has taken a minor role and in some areas is non-existent (IOM (Institute 
of Medicine), 2011).    
Federal regulation of public health falls under the purview of the Department of Health and 
Human Services (HHS), which include the CDC and the FDA. Under the federal level are the 
state and local public health agencies. Relationships between the state and local agencies vary 
across the country and can be divided into three models: decentralized-local public health 
operating independently of the state and reporting solely to local government or local boards of 
health; centralized-regional public health agencies, not local and shared; and mixed authority 
models-public health agencies reporting to either the state or local governments. In the U.S., 29 
states have decentralized public health agencies, six states and t the District of Columbia have a 
centralized public health system and the remaining 13 have a shared and mixed model. The lack 
of consistency, nationally, makes it difficult to create universal governing of public health 
programs. A unified approach to national public health programs will decrease disparities in 
distribution of the positive effects of such programs. Additionally, a cohesive approach can 
expedite the success of programs addressing issues that cross regional borders.   (Leep, 2006).  
7 | P a g e  
 
Both the state and local public health agencies typically share public health responsibilities with 
other governmental agencies and each state has its own set of public health laws. The complexity 
of public health‟s legal authority is beyond the scope of this paper, however the numerous 
variations across the nation creates concern that the development of public health programs 
aimed at national and global issues will face challenges in eliciting national cohesiveness. As 
stated previously, an issue such as antimicrobial resistance is not region specific and therefore 
will require cooperation and a unified front (IOM (Institute of Medicine), 2011).  
Despite these challenges, our government has created several successful policies that improve 
population health. Some of these are successfully managed, primarily, by public health agencies. 
Food and drug labeling and the control of health information are managed by the FDA and HHS, 
respectively.  Programs have been developed to decrease incidence in HIV transmission through 
clean needle programs and de-criminalizing HIV risk behaviors. Safety and prevention, such as 
seatbelt and helmet laws and water sanitation are also monitored and supported by public health 
agencies. Outside of the U.S., the United Kingdom (UK) successfully reduced their citizens‟ salt 
intake through a program started in 2003. The health authorities of the UK started working with 
food industry setting target goals of reduction through improved manufacturing of target foods. 
By 2010, it was noted that one major brand of chips contained 55% less sodium and the national 
average of salt intake fell from 9.5 grams in 2001 to 8.6 grams in 2010. The agency estimates 
that once the target goal of 6 grams of sodium intake a day is reached, they will have prevented 
20,200 premature deaths per year. Indoor clean air acts have also been regulated by U.S. public 
health agencies and a decreased exposure to second hand smoke was able to show a reduction in 
hospital admissions for acute coronary syndromes within months of these acts being enforced 
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(Juster et al., 2007). The issue still remains concerning the inconsistency of public health 
agencies‟ ability to enforce prevention programs nationally (IOM (Institute of Medicine), 2011).  
In 2007, the WHO supported the implementation of the International Health Regulations (IHR). 
One hundred and ninety-four state parties, including the United States, are involved in these 
efforts. The regulations are a legally binding set of health regulations that require participating 
agencies to enact a set of global rules that improve regional, national and global public health 
security. The IHR requires the reporting of specific disease outbreaks and significant public 
health threats to the WHO. The purpose of such actions is to limit the global spread of such 
tragedies and assist in their containment. The IHR also calls for participating countries to 
enhance and improve their public health surveillance systems, providing technical support as 
needed.  The IHR provides current information for international travelers regarding current 
health threats and outbreaks. Through the IHR the WHO has published guidelines for member 
states to utilize in the development and implementation of laboratory activities, safety features, 
biochemical transportation and field investigation. Additionally through the IHR, a global alert 
system is in place to assist with international public health threats (World Health Organization, 
2011). 
In light of the rationale behind the development of the IHR, the threat of antimicrobial resistance 
has been broached as a possible responsibility for the IHR to tackle. Much debate still exists, 
although AR as a global threat is well known. Through the IHR, the WHO is required to provide 
surveillance and recommendations of any potential global public health threat. A global early 
warning system would assist in the prevention and control of AR.  Barriers to such a system have 
been identified as political, technical and financial. For the WHO to be aware of a threat, they 
require notification. Many of the party states do not have the ability or technology to 
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comprehensively detect AR. In addition, notification may be thwarted by government agencies in 
an attempt to avoid blame for a potential outbreak. Finally, the WHO does not currently have the 
capability to track all resistant organisms (Wernli et al., 2011).  
Literature Review of Antimicrobial Resistance and Public Health   
In 1999 a congressional hearing on the issue "Antimicrobial Resistance: Solutions to a Growing 
Public Health Problem" resulted in the development of The Interagency Task Force on 
Antimicrobial Resistance (ITFAR). This task force brought together a variety of federal agencies 
to address the complex issue of antimicrobial resistance.  These agencies included the CDC, 
Food and Drug Administration (FDA) and the National Institutes of Health (NIH). A total of 10 
federal agencies currently comprise the task force (Centers for Disease Control and Prevention 
(CDC), 2011). 
In 2001 the ITFAR drafted A Public Health Action Plan to Combat Antimicrobial Resistance 
Part 1: Domestic Issues.  This publication was intended to be used as an outline for explicit 
federal actions to deal with antimicrobial resistance. This plan was the consensus of the ten 
federal agencies in the task force, with input from state and local public health officials, 
universities, healthcare organizations and many others invested in human health. In 2011, ten 
years after the initial report, the action plan was revised and publicized. These revisions brought 
the original plan more into focus, highlighting four key topic areas: surveillance, prevention and 
control, research and product development.  
This revision also addresses the global issue of antimicrobial resistance (AR) and the evolving 
dynamics of AR over extended periods of time. Specifically this revision suggests that a global 
approach will address the introduction of new pathogens to different regions based on 
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international travel and modifications based upon resistance patterns. Changes to the ITFAR 
action plan will be published every two years, with annual updates given on the progress of 
current action items (Centers for Disease Control and Prevention (CDC), 2011). 
The most recent published update was the 2009-2010 annual report. This 54 page document 
highlighted the four key topic areas and their action items. In total there were 53 action items 
listed. Under topic area two, prevention and control the overarching goal was to develop 
measures that will decrease the creation of antimicrobial resistant organisms and device 
strategies to prevent their spread. A few of the highlights of the progress made under this topic 
area are listed below. 
 In 2010 the United States licensed the use of a new pneumococcal vaccine in young 
children. This vaccine was developed to decrease incidence of antimicrobial-resistant 
pneumococcal infections. A CDC study is underway to determine its effectiveness. 
 The CDC‟s Get Smart program has developed education materials to educate primary 
care providers in proper prescribing of antibiotics. This program has provided this 
material to the Hospital Corporation of America (HCA) and was distributed to primary 
care practices in New Hampshire and Missouri. The HCA will monitor the prescribing 
practices in these areas and provide a report to the CDC. 
 The CDC will evaluate the Department of Veteran Affair‟s National MRSA prevention 
initiative which has presented their preliminary report and are awaiting peer review. In 
the preliminary report it was noted that MRSA infection was decreased by 24% in non 
intensive care unit (ICU) patients and by 77% in ICU patients.  
11 | P a g e  
 
These are just a few examples of progress being made by the IFTAR and the Public Health 
Action plan to Combat Antimicrobial Resistance (Centers for Disease Control and Prevention 
(CDC), 2011). 
Between 1990 and 2000 the World Health Organization (WHO) convened a series of meetings, 
workshops and consultative sessions to draft recommendations addressing the expanding public 
health threat of AR. These recommendations were published as the 2001 WHO Global Strategy 
for Containment of Antimicrobial Resistance.  Sixty-eight priority areas were addressed and 
centered on seven key groups.  
1. Patients and the general community  
2. Prescribers and dispensers  
3. Hospitals  
4. Antimicrobial use in food-producing animals 
5.  National governments and health systems  
6. Industry and research groups  
7. International organizations   
The recommendations listed in this publication focus on prevention of antimicrobial resistance as 
a whole and do not highlight specific pathogen directed strategies. The WHO recognizes that 
will be an individual endeavor of each member state to implement the suggested strategies with 
the additional need for international interdisciplinary cooperation. The challenge will be to get 
each member state to understand the relevance and importance of a unified approach toward the 
prevention and control of antimicrobial resistance. The 58
th
 World health Assembly Resolution 
on Antimicrobial Resistance 2005 states “despite some progress, the strategy for containment of 
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antimicrobial resistance has not been widely implemented” (The Fifty-eighth World Health 
Assembly, 2005). 
The National Antimicrobial Resistance Monitoring System (NARMS) was established by the 
FDA, CDC and U.S. Department of Agriculture (USDA) as a national public health surveillance 
system.  This surveillance system is currently being used to monitor enteric bacteria from food, 
animals and humans and test the bacterial susceptibility to antimicrobials. This system regularly 
communicates with other countries‟ surveillance systems in order to develop a more cohesive 
worldwide monitoring system (US Food and Drug Administration, 2011).  
Health departments that participate with NARMS send every twentieth isolate of each non-Typhi 
Salmonella, Typhi Salmonella, Shigella and E.Coli 0157 to the CDC laboratory for susceptibility 
testing. In addition 10 specified states send one Campylobacter isolate weekly to the CDC 
laboratory for the same testing. The data collect is then used to determine trends in resistance 
patterns and to mitigate efforts to thwart such threats before an outbreak can occur. 
Shortcomings of such program could be identified as underreporting and missed resistance in 
poor sampling numbers. Such shortcomings have not been published in the literature reviewed 
for this paper (US Food and Drug Administration, 2011). 
During World Health Day on April 7, 2011, WHO initiated a worldwide campaign for awareness 
of AR and to pursue policy change and support in the battle against AR.  The Infectious Disease 
Society of America (ISDA) published a position paper in honor of World Health Day. This 
position paper was published in the Clinical Infectious Disease Journal and provided a list of 
policy recommendations to be used in the fight against AR. The paper summarizes the IDSA‟s 
recommendations for how to approach the increasing threat of antimicrobial resistance and the 
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decrease in approval of new antimicrobial agents. The current recommendations speak to the 
current system of antimicrobial approval and the need for revisions. The position paper makes 
recommendations for economic incentives to entice companies to invest in the production of new 
antimicrobial agents and to revisit FDA procedures in the process of clinical trials in hopes to 
move the process along more efficiently, while still protecting human health. Recommendations 
to strengthen federal agency collaboration and leadership, in support of the Strategies to Address 
Antimicrobial Resistance (STAAR) Act (H.R. 2400 in the 11
th
 Congress) are highlighted, as well 
as the need for funding for such endeavors (Dellit et al., 2007).    
The ISDA‟s World Health Day  policy paper is a more current spin-off of a joint venture 
between the ISDA and Society for Healthcare Epidemiology of America (SHEA) in 1997. 
Together these organizations published a position paper based on recommendations formed from 
their Joint Committee on the Prevention of Antimicrobial Resistance. Similar recommendations 
are made in both publications with some variations based on the evolution of AR. Sadly, despite 
recognition of antimicrobial resistance‟s importance in 1997, 14 years later AR is still a present 
and ever growing threat to human health and vitality (Natsch, van Kasteren, Kullberg, & van der 
Meer, 1998).  
The remaining focus of this paper will be to review the current literature on the effectiveness of 
antimicrobial stewardship programs, determine best practices within these programs and 
establish the feasibility of public health leadership adopting aspects of these programs to develop 
universal policies, as well as advocate for funding and support to decrease antimicrobial 
resistance.  
Antimicrobial Stewardship Programs 
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“Antimicrobial stewardship refers to coordinated interventions designed to improve and measure 
the appropriate use of antimicrobials by promoting the selection of the optimal antimicrobial 
drug regimen, dose, duration of therapy, and route of administration” (Infectious Diseases 
Society of America (IDSA), 2011). 
Antimicrobial stewardship programs (ASP) were developed to determine the best approach to 
antimicrobial prescribing, decreasing costs of healthcare, improving patient outcomes and 
preventing further creation of antimicrobial resistance (Natsch et al., 1998). In 2007, the 
ISDA/SHEA position paper included guidelines for the development and implementation of 
antimicrobial stewardship programs.  ASP development can vary from institution to institution 
based on several internal and external factors.  However not all approaches are the most 
effective. A universal approach was the driving force behind the development of the position 
paper‟s guidelines (Dellit et al., 2007).   Table 1 illustrates an overview of the general strategies 
for antimicrobial stewardship programs. Each strategy emphasized is an instrumental component 
to all programs. This table provides a good summary of the actions needed, personnel required, 
and the advantages and disadvantages that may be encountered (MacDougall & Polk, 2005). The 
current literature will be reviewed for best practices in most of these strategies.  
Table 1 
Summary of antimicrobial stewardship strategies (MacDougall & Polk, 2005, pg 640) 
Strategy Procedure Personnel Advantages Disadvantages 
 
Education/guidelines Creation of guidelines for 
antimicrobial use 
Antimicrobial committee 
to create guidelines 
May alter behavior 
patterns 
Passive education likely 
ineffective 
 Group or individual education 
of clinicians by educators 
Educators (physicians, 
pharmacists) 
Avoids loss of 
prescriber autonomy 
 
Formulary/restriction Restrict dispensing of 
targeted antimicrobials to 
approved indications 
Antimicrobial committee 
to create guidelines 
Most direct control over 
antimicrobial use 
Perceived loss of autonomy 
for prescribers 
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  Approval personnel 
(physician, infectious 
diseases fellow, clinical 
pharmacist) 
Individual educational 
opportunities 
Need for all-hours 
consultant availability 
Review and 
feedback 
Daily review of targeted 
antimicrobials for 
appropriateness 
Antimicrobial committee 
to create guidelines 
Avoids loss of 
autonomy for 
prescribers 
Compliance with 
recommendations voluntary 
 Contact prescribers with 
recommendations for 
alternative therapy 
Review personnel 
(usually clinical 
pharmacist) 
Individual educational 
opportunities 
 
Computer 
assistance 
Use of information technology 
to implement previous 
strategies 
Antimicrobial committee 
to create rules for 
computer systems 
Provides patient-
specific data where 
most likely to impact 
(point of care) 
Significant time and 
resource investment to 
implement sophisticated 
systems 
 Expert systems provide 
patient-specific 
recommendations at point of 
care (order entry) 
Personnel for approval or 
review (physicians, 
pharmacists) Computer 
programmers 
Facilitates other 
strategies 
 
Antimicrobial cycling Scheduled rotation of 
antimicrobials used in hospital 
or unit (e.g., intensive care 
unit) 
Antimicrobial committee 
to create cycling protocol 
May reduce resistance 
by changing selective 
pressure 
Difficult to ensure 
adherence to cycling 
protocol 
  Personnel to oversee 
adherence (pharmacist, 
physicians) 
 Theoretical concerns about 
effectiveness 
 
 
ASP guidelines were also included in the 2011 position paper published by the ISDA for World 
Health Day.  These more current recommendations fall under topic area five: Strengthening 
Activities to Prevent and Control Antimicrobial Resistance. The ISDA/SHEA ASP position 
paper emphasizes that universal guidelines and universal acceptance of these guidelines need to 
be established so that ASPs can be implemented in all settings of healthcare from hospitals of all 
sizes to private practice and in between (Infectious Diseases Society of America (IDSA) et al., 
2011).   
One potential setback to the lack of complete success of ASPs is that each program‟s 
characteristics and interventions vary on numerous levels, from institution to institution. There is 
no universal program or universal policing of said programs. Every institution varies in the 
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administrative support for ASPs and the personnel and financing provided for these programs, 
creating a lack of consistency among programs. Without mandates, neither requiring ASPs nor 
financing provided through government programs, a universal approach is unlikely (Infectious 
Diseases Society of America (IDSA) et al., 2011).  The variations among ASP characteristics 
will be more evident in the results of the systematic literature review of APSs.  
Methods 
A systematic review of the literature was developed to answer our primary research questions.  
What are the most effective strategies being used by antimicrobial stewardship programs? Is it 
possible to form a universal ASP from these proven best practices to be implemented and 
governed by public health agencies? A literature review was conducted using three databases: 
PubMed, Cumulative Index to Nursing and Allied Health Literature (CINAHL), and EMBASE. 
A total of 26 articles for review were ultimately selected following search parameter adjustments 
as detailed below.  
The search terms “antimicrobial stewardship” OR “antibiotic stewardship” was used for PubMed 
and CINAHL for a return of 309 articles and 102 articles, respectively.  The search parameters 
were adjusted slightly for the EMBASE database, based on the search structure of that database. 
For EMBASE the search term, “antimicrobial stewardship” OR “antibiotic stewardship” AND 
([embase]/lim OR [embase classic]/lim). This search resulted in 441 articles. The search was 
further limited by the addition of filter to each of the databases. The filters of only English 
articles, only human research and only research articles were applied to each database with the 
publishing time parameters of January 1, 2000 through December 31, 2011.  This resulted in 92 
article matches in PubMed, 12 article matches in EMBASE and 40 article matches in CINAHL.  
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A quick review of each of the articles for relevance was then performed.  Articles that focused on 
hospital, community or government programs were included. Articles that focused on 
Clostridium difficile infection or specific organism‟s resistance patterns or studies were 
excluded.  This then resulted in 31 articles in PubMed, nine articles in EMBASE and 18 articles 
in CINAHL for a total of 58 articles. All of the selected articles were then uploaded into 
RefWorks and duplicates we extracted, resulting in a total of 52 article matches. 
These 52 remaining articles were then reviewed further for inclusion and exclusion criteria. It 
was determined that any article that was a research article focused on the assessment of all or a 
specific aspect of an antimicrobial stewardship program was to be included in this literature 
review.  These included mostly hospital based programs, and some government based programs.  
Exclusion criteria were articles that were not study based, were not a review of part of or all of 
stewardship programs or were too focused on a specific pathogen.  Articles that focused only on 
the pharmacist‟s role and view were excluded.  Finally it was decided that inclusion of articles 
describing guidelines and research on behavioral aspects would be included if they appeared to 
address important aspects of ASP and could assist in determining best and failed practices to 
include in the recommendations.  This analysis of the research resulted in a total of 18 articles to 
be included in the final literature review for this paper. 
Results 
The 18 chosen articles for this literature review were analyzed and broken down into several 
categories for review.  Those aspects of the literature that were felt to be important 
characteristics of ASPs and were considered key features of the success and failures of said 
programs were chosen for review categories.  The primary goal of the collected data was to make 
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recommendations based on the current literature for the feasibility and design of a universal ASP 
initiative to be implemented by public health leadership. 
Current Antimicrobial Stewardship Programs 
In 2000, Lawton, Fridkin, Gaynes, and McGowan published a cross-sectional survey that was 
developed to determine the status of programs developed to improve the use of antimicrobials in 
US hospitals. The participants were staff from 47 hospitals that were taking part in phase 3 of 
Project Intensive Care Antimicrobial Resistance Epidemiology.  They were using the 1997 
SHEA/IDSA position paper recommendations as guidance for their programs. It was determined 
from this study that while all 47 hospitals had some form of a program to improve antimicrobial 
usage, there was very little consistency in practices among institutions in the study. All 
institutions included some form of an antibiotic formulary and consultation with a pharmacist or 
infectious disease physician prior to ordering antimicrobials was required. Recommendations 
from the SHEA/IDSA position paper indicate that it is not enough to just limit antimicrobial use. 
Education and guidelines, in addition to monitoring systems, were strongly encouraged. Seventy 
percent of the hospitals reported having clinical practice guidelines, but dissemination of these 
guidelines varied among institutions and less than half had a system in place to measure 
compliance. Lack of consistency among stewardship practices and lack of accountability were 
highlighted as a prevalent finding among ASPs, despite the 1997 guidelines (Lawton, Fridkin, 
Gaynes, & McGowan, 2000). 
In 2006, Barlam and DiVall, published a study that conducted two surveys looking at the ASP 
practices. The first survey was used to elicit information regarding ASP practices at 22 top 
academic medical centers in the United States (US). The second was a mailed survey to 97 
teaching and community hospitals throughout Massachusetts. Fifty-four, (56%), of the surveys 
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were returned and analyzed.  Fifteen of the 22 hospitals were chosen for the first survey from the 
2001 U.S. News and World Report, ranked as “Americas Best Hospitals”. The other seven 
hospitals were chosen based on their interest and extensive publishing on antibiotic usage and 
improved practices (Barlam & DiVall, 2006).   
The results of the first survey showed that all 22 hospitals had developed some form of 
antimicrobial stewardship, with an objective of improving antimicrobial dispensing and 
prescribing.  Table 1 provided a comprehensive summary of recommended strategies for ASPs. 
In comparison of the findings of this study and Table 1; education, computerized assistance, 
formulary restrictions and antibiotic approval were utilized, however their use varied 
extensively. Among the fifteen top institutions, nine had widespread antibiotic restrictions and 
two had no formulary restrictions. Among those with formulary restrictions, infectious disease 
fellows were responsible for antibiotic approval in nine of the programs. However structured 
education of these fellows was only provided at one of these institutions. Other programs 
provided training either through review of approvals with program directors or with a lecture at 
the start of their fellowship. Only six of the 22 hospitals used computer assistance for antibiotic 
guidance and approval. There were no measures for feedback or for determining prescribing 
practice trends in place at any of the institutions surveyed. Finally, funding and support for the 
studied programs was considered the greatest barrier for all institutions. Despite the presence of 
these programs, physician compliance and acceptance varied from rare to 85% (Barlam & 
DiVall, 2006). 
 In the second survey, it was determined that teaching hospitals in Massachusetts were more 
active in ASPs activities compared with community hospitals in the state. Antibiotic restriction 
formularies were implemented in 95% of teaching hospitals as compared to only 49% of the 
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community hospitals. In teaching hospitals with formulary restrictions, an antibiotic approval 
process was in place in 94% of these institutions. In the community hospitals only 29% of those 
with formularies had an approval process (Barlam & DiVall, 2006).  
In conclusion of this study, recommendations for multicenter research to identify various 
effective interventions to reduce antimicrobial resistance were encouraged. The authors believe 
that these standards should also be included into accreditation agencies requirements, in hopes 
that administrators will financially and structurally support ASPs (Barlam & DiVall, 2006). 
Two more studies conducted in 2009 and 2011 highlighted the variability between ASP 
programs in similar institutions and lack of regard for recommended guidelines and practices 
supported by IDSA. In 2009, Hersh, Beekmann, Polgreen, Zaoutis, and Newland published a 
study that surveyed 147 pediatric infectious disease consultants. This survey again showed a 
variation in implementation of the programs. First of all, only one third of the respondents 
reported having an ASP at their facility. Seventy-eight percent reported using a prior 
authorization, but only one third of those incorporated prospective feedback and review, a 
foundational tactic in the IDSA recommendations (Hersh, Beekmann, Polgreen, Zaoutis, & 
Newland, 2009). In 2011, Van Schooneveld, Miller, Sayles, Watkins, & Smith, reviewed ASPs 
in long-term care facilities in Nebraska. The results revealed that almost 60% of long-term care 
facilities surveyed in Nebraska had an existing ASP. However, the study determined that despite 
research and IDSA recommendations, most of these programs were managed by a single person 
or single discipline (Van Schooneveld, Miller, Sayles, Watkins, & Smith, 2011).   
IDSA/SHEA recommendations call for a multi-disciplinary leadership approach to ASPs. The 
inclusion of an infectious disease physician(s), clinical pharmacists with infectious disease 
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training, epidemiologist and an infection control professional is considered a gold standard. They 
also recommend a clinical microbiologist to assist in surveillance (Dellit et al., 2007). 
Program Design of ASP    
A study conducted by Johannsson et al published in 2011, surveyed physician members of the 
IDSA EIN.  The purpose of the survey was to determine prevalence and attributes of ASPs in the 
US as well as to determine financial support for these programs. This study revealed that of those 
responding to the survey, 89% reported involvement with their facilities ASP.  It was also 
ascertained that 91% of those programs also included pharmacists, 33% infection control 
professionals and 33% microbiologist (Johannsson et al., 2011). 
A study at Concord hospital in Australia concluded that 83% of physicians surveyed supported 
an infectious disease specialist or microbiologist as the best persons to advise antibiotic usage 
(Bannan, Buono, McLaws, & Gottlieb, 2009). ASP‟s leadership at the Children‟s Hospital of 
Philadelphia included two doctoral level clinical pharmacists and an infectious disease physician. 
Metjian, Prasad, Kogon, Coffin, and Zaoutis conducted a study published in 2008, at that facility 
evaluating ASPs in pediatric teaching hospitals. It was found that ASPs were responsible for 
close to 50% of the antibiotic decision making during the study period and that participants 
found the guidance useful and effective (Metjian, Prasad, Kogon, Coffin, & Zaoutis, 2008). 
Education 
Another important aspect of any antimicrobial stewardship program is the inclusion of 
educational activities. Knowledge drives practice, and it has been shown in the current literature 
that educational programs have improved adherence to a support of ASPs, specifically by 
participating medical providers (Dellit et al., 2007).  
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Charani et al., 2011, conducted a systematic review of the literature from 1999 to April 2011, 
assessing antibiotic prescribing behavior in acute care settings. The study demonstrated evidence 
that social norms, beliefs and attitudes influence prescribing behaviors (Charani et al., 2011). 
Each of these determinants can be influenced through education, however it has been shown that 
knowledge without active intervention results in marginal changes and effectiveness (Danaher, 
Milazzo, Kerr, Lagasse, & Lane, 2009).  
In 2006 the David Grant USAF Medical center participated in a prospective, randomized study 
assessing the effectiveness of an education program regarding antimicrobial use.  The end-points 
were defined daily doses (DDD) of antibiotics per patient treatment and days of antibiotic 
therapy (DOT) per patient treatment. A reduction in both DDD and DOT was observed in the 
intervention group as compared to the control group: 
 DDD reduction DOT reduction 
Intervention Group 6.7 +/- 7.6 doses 4.5 +/- 3 days 
Control Group 12.9 +/- 16.3 doses 6.6 +/- 4.6 days 
 
The reduction of DDDs was statistically significant, with a p-value 0.05 and the reduction of 
DOTs had a marginally significant p-value of 0.06. Both showed improvement in antimicrobial 
usage when educational programs were employed (Danaher et al., 2009). 
Conversely, it was shown in Van Schooneveld‟s survey of LTCF in Nebraska that one of the 
greatest barriers to efficacy of ASPs was noted to be the prescribers‟ attitudes and actions toward 
program guidelines. Prescribers were found to have a treat-first attitude, and did not fully 
understand the impact of antibiotic misuse. Feedback from other healthcare professionals was 
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not welcomed and routinely rejected.  Such actions can easily be attributed to a lack of 
knowledge or understanding, all of which could be resolved with an effective educational 
campaign (Van Schooneveld et al., 2011). 
Effective Strategies   
Various approaches to implementation and execution of ASP have been observed in this 
literature review. Diverse methods have proven successful in both the reduction of misuse of 
antimicrobials, as well as generating support and adherence by staff at certain facilities (Bannan 
et al., 2009; Van Gastel, Costers, Peetermans, Struelens, & Hospital Medicine Working Group of 
the Belgian Antibiotic Policy Coordination Committee, 2010) .  
Concord Hospital in Australia is a 450 bed acute care facility. The ASP in use at Concord 
hospital requires medical staff to page the Infectious Diseases Unit to receive prior approval of 
restricted antibiotics. The pager is rotated among infectious disease staff, and if not available, the 
pharmacists will provide 24 hour dose of prescribed antibiotic but require approval for 
continuation. The pharmacist supervises observance of the policy and infectious disease 
physicians counsel departments on correct formularies for specific infections (Bannan et al., 
2009). 
Bannan et al. conducted a survey of junior and senior medical staff to determine their opinions of 
the current program, concerned with their impact on the future efficacy of the program. One 
hundred sixty-four surveys were returned out of 440. The results of the survey revealed that 82% 
had used the system, 98% felt that an antibiotic restriction policy was fair, and that it required 
careful consideration prior to prescribing. The respondents also reported that they saw the 
program as a means to reducing antimicrobial resistance (Bannan et al., 2009). 
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The Belgian Antibiotic Policy Coordination Committee (BAPCOC) has supported the 
development of antibiotic management teams (AMT) since 2002 by allocating funding, 
providing technical support and specialist training. In 2010, Van Gastel, Costers, Peetermans, 
Struelens, and Hospital Medicine Working Group of the Belgian Antibiotic Policy Coordination 
Committee published a survey of AMT‟s activities and services in Belgian hospitals in 2007. 
AMTs are the equivalent of ASPs in the US. They function in an acute care setting to reduce 
antimicrobial resistance through proper use of antimicrobial agents. In Belgian hospitals it was 
found that AMTs interacted regularly with both infectious disease specialist and pharmacists. 
AMTs used multiple means of communication with prescribers as well as made the frequent 
presence of infectious disease physicians or clinical microbiologists on the floors or at staff 
meetings. Belgian hospitals supported by the BAPCOC were found to have well defined, 
structured and comprehensive AMTs. Funding and support from national health care leadership 
was present and credited with the programs successes. Table 2 shows a breakdown of the 
various initiatives implemented at these acute care settings as funding was made available (Van 
Gastel, Costers, Peetermans, Struelens, & Hospital Medicine Working Group of the Belgian 
Antibiotic Policy Coordination Committee, 2010). 
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Table 2 
Implementation of antibiotic stewardship initiatives in the acute care hospitals according to the time at which they first received 
financial support for their AMT and the number of beds, by percentage (Van Gastel et al., 2010, pg 578) 
Antibiotic stewardship initiative 
Group A 
(2002) 
Group B 
(2006) 
Group C 
(2007) 
≤400 
beds 
401  800 
beds 
>800 
beds 
Total 
Antibiotic formulary 100 95.6 93.7 92.4 100 100 96.3 
Guidelines for empirical and aetiological 
antibiotic therapy 
100 91.3 85.1 90.4 90.2 100 91.6 
Guidelines for antibiotic prophylaxis 100 95.6 93.7 92.4 100 100 96.3 
Antimicrobial order forms 51.4 39.1 22.9 30.2 36.6 57.1 36.1 
Requirement of justification and/or authorization 
for specific antibiotics 
86.5 95.6 58.3 64.1 82.9 100 75.9 
Prospective audit with intervention and feedback 86.1 73.9 42.5 51.9 73.2 84.6 64.2 
Automatic stop order 64.9 47.8 25 37.7 46.3 57.1 43.5 
Streamlining or de-escalation of therapy 75.7 73.9 50 54.7 68.3 85.7 63.9 
Parenteral to oral conversion 86.5 91.3 66.7 81.1 73.2 85.7 78.7 
Analysis of antibiotic consumption 100 100 91.3 94 97.6 100 96.2 
Analysis of microbial resistance 97.3 95.6 81.2 84.9 95.1 92.9 89.8 
 
Electronic antibiotic stewardship was studied by Buising et al in 2006 in a teaching hospital in 
Melbourne Australia. Using a computerized approval system for antimicrobial use, prescribing 
practices, resistance patterns and patient outcomes were analyzed. The study was able to show 
that a computerized approval system that is designed by knowledgeable clinicians is an effective 
avenue for prescribing.  The system was accepted by providers. A positive change was observed 
in antibiotic prescribing habits and a noted decrease in resistant strains of Pseudomonas spp. and 
S. Aureus occurred (Buising et al., 2008). 
Finally, care bundles are defined as a group of actions based on evidence- that are employed for 
a specific period of time. Their inclusion into ASPs was reviewed in a study conducted by Toth, 
Chambers, and Davis, published in 2010. The care bundle in this study was defined as the 
intervention of a clinical pharmacist in patient care. The clinical pharmacist worked with the 
medical team in the direct care of patients receiving selected antibiotics. The pharmacist‟s role 
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was to monitor the patient‟s cultures and antibiotic therapy, suggest appropriate changes to 
antimicrobials and to conduct four to five education sessions a month focusing on the facilities 
resistance and susceptibility profiles. The control group was a retrospective review the year prior 
of patient outcomes and susceptibility using the same antimicrobials and patient inclusion 
criteria. The study was looking at care bundle‟s impacts on compliance in an acute care center.  
It was determined that compliance with quality indicators such as documentation of treatment 
rationale, collection of cultures and appropriate empirical and definitive antimicrobial usage with 
the cessation of antimicrobials if no infection is found,  improved dramatically with the 
introduction of care bundles. Compliance rates were found to increase from 16% to 43% with a p 
value of < 0.001 (Toth, Chambers, & Davis, 2010). 
Barriers 
Barriers to effective stewardship programs have also been identified in the current literature. 
Johannsson et al published a study in April 2011 focused on the evolution of strategies and 
barriers. This study surveyed members of the IDSA EIN who care for adult patients and received 
a 50% response rate.  Primary barriers for the success and implementation of an effective ASP 
identified by physician members were lack of funding, lack of administrative support, limited 
provider compliance, inadequate or absent technical support and higher priority clinical 
initiatives. Table 3 shows data from the study on ranking of barriers from most common (1) to 
least common (7). Lack of funding, lack of personnel and administrative support were ranked the 
most prevalent barriers to developing and effective program. Approximately 50% of the 
respondents reported that they received no compensation for their involvement in their 
institutions ASP. Additionally, hospital administrative support was found to be lacking in most 
hospitals where cost saving was considered the primary goal of the programs, despite the proven 
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cost effectiveness of ASP (Johannsson et al., 2011); (Dellit et al., 2007). One study showed a 
32% decrease in expenditures on antimicrobials after the initiation of their ASP, as well as a 
significant reduction in resistance (White et al., 1997) 
Table 3  
Rank Order of Barriers to a Functional and Effective Antimicrobial Stewardship Program (ASP)(Johannsson et al., 2011 pg 371) 
  No ASP Planned ASP Current ASP 
Barrier Median Mean ± SD Median Mean ± SD Median Mean ± SD 
Lack of funding or personnel 2 2.2 ± 1.6 1 1.4 ± 1.0 1 2.3 ± 1.7 
Other higher-priority clinical initiatives 3 3.1 ± 1.7 3 3.0 ± 1.6 3 3.1 ± 1.5 
Administration not aware of value of ASP 3 3.0 ± 1.7 3.5 3.5 ± 1.8 4 4.0 ± 1.8 
Opposition from prescribers 4 3.6 ± 1.7 4 3.8 ± 1.7 3 3.3 ± 1.8 
Lack of informaton technology support and/or inability to get data 4 4.4 ± 1.9 3 3.7 ± 1.8 4 4.0 ± 1.9 
Other specialties antagonized by ASP 4 4.0 ± 1.6 5 4.7 ± 1.7 4 4.1 ± 1.8 
Multiple infectious disease groups within facility 7 5.3 ± 2.3 7 6.2 ± 1.4 7 5.9 ± 1.9 
Note No barriers were reported by 3 respondents with a planned ASP (5%) and by 38 respondents with a current ASP (13%). 
Rank: 1, most common; 7, least common. 
Several other studies have identified similar barriers to implementation and effective utilization 
of ASPs. Provider compliance is a major issue noted in a few studies assessed in this literature 
review (Hersh et al., 2009; LaRosa et al., 2007; Van Schooneveld et al., 2011)). LaRosa et al 
describe “stealth dosing” in a cross sectional study published in 2007. Antimicrobial ordering 
was assessed at an acute care hospital that had a prior-approval time period for ordering targeted 
antibiotics. Prior approval for antibiotic ordering ended at 2200 hours each evening, resuming in 
the morning. This study assessed orders that occurred between the hours of 2100-2159 and the 
orders that occurred from the hours of 2200-2259. It was determined that more of the antibiotic 
orders between 2200-2259 hours were for restricted medications than those that were ordered 
from 2100-2159 hours. It was also determined that more of the antibiotics ordered after the prior 
approval time frame were deemed inappropriate and discontinued than those ordered during the 
prior approval periods (LaRosa et al., 2007).   
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Site Specific ASP Reviews 
Systematic literature review also produced four studies that assessed antimicrobial stewardship 
in specific hospital settings. These included emergency departments, intensive care units and 
pediatrics units.  All four studies identified practicality and effectiveness in each of the settings, 
with an improvement in antibiotic use found in the ICU. (Acquisto & Baker, 2011; Hersh et al., 
2009; Kaki et al., 2011; Metjian et al., 2008). Stewardship programs in the pediatric setting were 
found to be few. Of those programs in existence, it was shown that most did not monitor end 
points such as compliance rates, redundant therapy or improper antibiotic usage. In this same 
study, 50% of the 147 pediatric infectious disease consultants did not feel that antibiotic 
resistance was an issue at their hospital, despite 80% of the same respondents stating resistance 
was a national crisis issue (Hersh et al., 2009). 
Kaki et al. conducted a systematic review in 2010 assessing the effectiveness of ASPs in the 
critical care setting. The results of the study showed a positive decrease in antimicrobial usage, a 
decrease in hospital stays per patient, less money spent on antimicrobials and shorter duration of 
antimicrobial administration. Additionally, ASPs were not associated with an increase in 
mortality or hospital acquired infection rates. Limitations of this study were based on the few 
research studies conducted on the topic, but a positive outcome in ASPs in critical care settings 
was seen from the analysis of their literature (Kaki et al., 2011).  
Government ASPs 
The current literature was also reviewed for studies that focused on government enforced and 
supported ASPs. Four studies were identified in the systematic search. Van Gastel et al‟s study 
was able to profile comprehensive ASP‟s that had impressive support both financially and 
29 | P a g e  
 
structurally. In addition, the study emphasized that with such support effective programs can be 
developed (Van Gastel et al., 2010). 
In 2011, Dumartin et al published two studies that assessed trends in antibiotic use with ABS 
measures in south-western French hospitals and their associations. These studies were conducted 
between 2005 and 2009. Health authorities in France support the development of ASPs in acute 
care centers and a legal framework was established by the French Ministry of Health for the 
development of ASPs (Dumartin, Rogues, Amadeo, Pefau, Venier, Parneix, & Maurain, 2011a). 
The Dumartin studies also concluded that with the right amount of personnel, multidisciplinary 
staff and governmental support, antibiotic use is better controlled (Dumartin, Rogues, Amadeo, 
Pefau, Venier, Parneix, & Maurain, 2011b). 
Multiple endeavors supporting antimicrobial stewardship have been undertaken in Europe. A 
study by Allerberger, Gareis, Jindrak, and Struelens published in 2009, reviewed hospitals‟ 
APS‟s initiatives and their objectives. Standards of these programs are outlined, and the use of 
these standards by accreditation bodies as framework for support of ASPs was recommended. 
Again an interdisciplinary team is suggested for leadership of the programs and education is 
highlighted as a key to gaining provider support. Barriers in Europe are indentified as similar to 
those in the US, including funding acquisition and appropriately trained staff to manage the 
programs. The study concludes that successful implementation of stewardship programs require 
dealing with three major gaps: (1) further research to determine cost effectiveness of ASPs and 
to determine effectiveness of differing approaches; (2) development of evidence-based best 
practices through expert consultation and research and (3) enhancing legal basis and funding for 
antimicrobial stewardship programs (Allerberger, Gareis, Jindrak, & Struelens, 2009). 
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Discussion/Future Direction 
“In 1967, U.S. Surgeon General William H. Stewart told a White House gathering of health 
officers that „it was time to close the book on infectious diseases and shift all national attention 
(and dollars) to what he termed „the New Dimensions‟ of health: chronic diseases‟” (Forum on 
Microbial Threats, 2006).  Over the past four decades since that statement, 37 new infectious 
human pathogens have been identified. Additionally, 12 known infectious human pathogens 
threaten human heath through re-emergence (Mueller, Merrell, Grimm, & Falkow, 2004). In 
2001, infectious disease had a worldwide mortality rate of 26% (Forum on Microbial Threats, 
2006).  The “book” appears to have a sequel, one that is far from being finished.  
Antimicrobial resistance was actually recognized prior to the FDA approval of penicillin. In the 
September 1945 publication of Miscellany News this quote was taken. 
“Dour, white-thatched Sir Alexander Fleming, discoverer of penicillin, is fearful of the 
consequences of uncontrolled distribution of his „baby.‟ In a recent interview Sir 
Alexander remarked that there was danger of „educating the microbe to resist penicillin.‟ 
In his talk at a dinner tendered him by penicillin producers and the following evening he 
again referred to this fear. „The greatest possibility of evil in self-medication is the use of 
too small doses so that instead of clearing up the infection, the microbes are educated to 
resist penicillin and a host of penicillin-fast organisms is bred out.‟ But he went on to 
express the hope that this danger could be averted”(Miscellany News, 1945, pg 153). 
 
Even in the 1940s it was known that misuse of antibiotics could lead to antimicrobial resistance, 
but it was not until 1997 that recommendations for surveillance, prevention and control were 
published. Hence, we are now faced with an enormous public health threat that is a global issue, 
because antimicrobial resistance knows no geographic boundaries. Such a colossal task cannot 
be effectively handled by individual organizations. Public health leaders need to take a firm 
position concerning this and, just as in the early twentieth century, direct us to an era where 
microbes are in our control.  The IHR would be the most suitable organization to regulate efforts 
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for a global approach, but many barriers still need to be addressed. Although antimicrobial 
stewardship programs are just one variable in the battle against antimicrobial resistance, they 
could be our greatest defense (Infectious Diseases Society of America (IDSA) et al., 2011; 
Miscellany News, 1945).   
A systematic review of the current literature on ASPs shows that although guidance is available, 
most current programs leave much to be desired. In addition there does not appear to be any 
universal oversight, specifically in the United States (Barlam & DiVall, 2006; Lawton et al., 
2000).  Multiple studies have proven repeatedly that misuse and over use of antimicrobials are 
the primary avoidable causes to resistance (Cohen, 1992; Craig et al., 1978). This must be our 
focus, and the best approach is through a standardized program for surveillance, prevention and 
control.  ASPs are a valuable start in that venture.  
Although autonomy is regarded as a right by health care providers, the threat of AR is too great 
to ignore a necessarily structured approach to the problem. Policy and law should to be 
developed in order that an objective and effective treatment program can govern antimicrobial 
use for the betterment of mankind. The objective is to cause a decrease in antimicrobial 
resistance, an increase in susceptibility, and the development of more antimicrobials for our 
treatment arsenal. Although a global approach would be ideal, each country needs to take 
responsibility for such action to start. In the U.S., public health leadership, such as the HHS and 
CDC should administer resistance programs at a government level. They should be responsible 
for eliciting support from higher officials, both financially and structurally. Public health leaders 
at the national level should guide research based on current local, national and global resistance 
trends, continue to assess interventions, and maintain compliance from individuals and 
institutions.  
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The literature shows us that it will be difficult to enforce one set of guidelines (Dellit et al., 2007; 
Lawton et al., 2000).  Healthcare institutions are unique to their setting, environment, culture and 
size.  This is true of resistance patterns as well.  Acute care settings differ from community and 
private practices and each health care practitioner has his or her own set of beliefs and 
preferential treatment modalities. Autonomy is a hallmark of practice as a physician or advanced 
practice provider, and most practitioners would not easily abandon this autonomy lightly. These 
factors highlight the complexity of a universal program.  Despite all of the above, it is still a 
possibility.  The current literature reveals some very effective strategies, successful government 
managed and supported practices and highlights the challenges (Dumartin, Rogues, Amadeo, 
Pefau, Venier, Parneix, & Maurain, 2011a; Van Gastel et al., 2010). Much is already known, but 
need to be organized and accepted in order to move closer to a successful program applicable to 
all. 
It was shown in Van Gastel‟s study focusing on Belgian hospitals in 2007, that a successful 
program can be developed and undertaken effectively with strong support and backing from 
government health officials (Van Gastel et al., 2010). In review of the current literature key 
elements were highlighted as being themes influencing successful programs. 
 Sufficient funding 
o Provides the means necessary to develop programs as well as compensate the 
specialists and staffing required to support the programs. 
 Administrative backing 
o A successful program requires administrative support for the necessary resource 
allocation, as well as for collaborative leadership.  
 Wide scale education 
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o Education of staff, community partners and the general population is required for 
a comprehensive understanding of strategies, the issue at hand and corrective 
actions. Education also assistance with compliance rates. 
 Compliance from healthcare providers 
o In order to decrease antimicrobial resistance proper use of antimicrobials is 
necessary. Compliance of healthcare providers with current recommendation is at 
the heart of proper antimicrobial usage. 
 Multidisciplinary leadership for each program  
o A multidisciplinary approach provides expertise from various specialties. In 
addition collaborative efforts assist in sharing the workload in managing the 
programs.  
 Technological support and availability  
o Computer assisted programs provide antimicrobial guidance, management, 
decision-making feedback and training programs. This allows for a larger 
audience reached in a timely fashion.  
Diverse approaches can and should be developed to meet the complex nature of healthcare. No 
single system will work for all.  As a set of strategies achieves the endpoint of decreasing AR 
and increasing susceptibility, then they should be included in future guidance. Continual searches 
for new and effective approaches will only assist in assuring future success.    
The Public Health Core Competencies were published as guidance for the set of skills required 
for public health professionals to possess to be successful in the delivery of essential public 
health services. A review of the essential public health services only enhances the argument that 
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the coordination and enforcement of ASPs is an essential public health role (Council on Linkages 
Between Academia and Public Health Practice, 2001).  
 Monitor health status to identify community problems  
 Diagnose and investigate health problems and health hazards in the community  
 Inform, educate and empower people about health issues  
 Mobilize community partnerships and action to solve health problems  
 Develop policies and plans that support individual and community health efforts  
 Enforce laws and regulations that protect health and ensure safety  
 Link people to needed personal health services and assure the provision of healthcare 
when otherwise unavailable  
 Assure an expert public health workforce  
 Evaluate effectiveness, accessibility, and quality of health services  
 Research for new insights and innovative solutions to health problems  
These skill sets enable public health professionals with the knowledge and ability required for 
such an endeavor (Council on Linkages Between Academia and Public Health Practice, 2001). 
In 1988, the Institute of Medicine published The Future of Public Health. This report highlighted 
the importance of public health leadership development.  In response to this report the CDC 
established the National Public Health Leadership Institute and provided funding for state and 
regional leadership institutions (Saleh, Williams, & Balougan, 2004). In addition to the Public 
Health Core Competencies, leadership education and training has made a major impact on public 
health practice. These programs improve upon the skill sets of public health workers and their 
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ability to create positive and effective changes to health programs (Leadership Development 
National Execllence Collaborative, 2001).  
The National Public Health Leadership Development Network, under HHS, developed the Public 
Health Leadership Competency Framework as a guidance tool for assessing leadership skills and 
developing training programs. This framework focuses on four core competencies; 
transformational competencies, political competencies, trans-organizational competencies and 
team building competencies. Within these four core competencies are subsets of skill sets that 
enhance each core mission (National Public Health Leadership Development Network, 2005).    
 Core Transformational Competencies 
o Visionary Leadership 
 To develop and share an embodiment of innovative ideas for future 
directions and to encourage others to share this vision 
o Sense of Mission 
 The personification of values, beliefs and ethics and the facilitation of 
mission development 
o Effective Change Agent 
 Optimizing learning, critical thinking and analytical skills through creative 
means. 
 Facilitates these changes into practical situations 
 Political Competencies 
o Political Process 
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 Identification of policy issues and the development of alternative avenues 
to implement public health programs 
o Negotiation and Mediation 
 Mediation and guidance through public health crises through investigation 
and resolution 
 Identification of key stakeholders and resources 
o Ethics and Power 
 The identification of power-based alliances and collaborative actions with 
an ethical and value-based framework  
o Marketing and Education 
 The utilization of social media to communicate with and educate target 
audiences 
 Trans-organizational Competencies 
o Organizational Capacity and Dynamics 
 The creation of assessment models to assess organizational environment, 
their needs and assets and identifies opportunities all in relation to a 
specific mission and vision 
o Trans-organizational Capacity and Collaboration 
 The inclusion of key stakeholders, players and personnel in collaborative 
efforts 
 The development of partnership strategies, such as, task forces, coalitions 
and teamwork activities 
o Social Forecasting and Marketing 
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 Identifies emerging trends and predicts scenarios to act upon 
 Utilization of social media for communication 
 Team building Competencies 
o Team Structures and Systems 
 Develops and drives team building activities and promotes organizational 
learning 
 Creates ownership and pride amongst the team members 
o Team Development 
 Clear goals and objectives 
 Shared mission and values 
 Develops problem solving, conflict resolution and decision making skills 
within the members 
o Facilitation and Mediation 
 Establishes team member roles 
 Mentors and coaches team members 
o Effective Role Modeling 
 Models listening, negotiating, encouraging, motivating, integrity, 
credibility, enthusiasm, trust and commitment 
Each of the above skill sets provides solid leadership abilities to initiate and enforce 
antimicrobial resistance programs. Additionally, the application of collaborative leadership has 
been shown to be an effective strategy for making a positive impact on public health programs. 
Collaborative leadership uses supportive methods to ensure that all individuals impacted by a 
decision are included in the change process. This approach empowers many, allowing for 
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strength in numbers (Leadership Development National Execllence Collaborative, 2001). With 
relation to ASPs, a collaborative approach would, minimally, include leadership from hospital 
administrators, infectious disease physicians, pharmacists, laboratories, and a public health task 
force. Together these leaders would need to take on the mission of decreasing antimicrobial 
resistance through proper antimicrobial usage. Guidance has been provided for the development 
of ASPs, however each participant in the program should be encouraged to actively participate in 
the development of such a program. Public health professionals should lead this initiative 
utilizing the leadership skill sets set forth by the Public Health Leadership Network 
Development. Task forces can be created to develop best practices related to the development of 
a universal ASP. A facilitator from the public health departments can lead each group acting as 
both a mediator and a visionary, empowering each group to complete each task with ownership 
and pride. The development of such a program will be challenging but with strong leaders at the 
helm, nothing is impossible (Leadership Development National Execllence Collaborative, 2001; 
National Public Health Leadership Development Network, 2005).  
Below is a logic model created from the current literature review in this paper. It incorporates 
best practices identified in the literature and is suggested as a model to guide future development 
of ASPs. As stated already, many barriers exist towards the development of a set of universal 
stewardship programs but the skill sets required to manage such a task have already been proven 
by past and current public health endeavors, led by public health leaders.   
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Figure 2 is a Logic Model of Antimicrobial Stewardship Program development for public health leadership. It was designed based on the evidence from the 
literature review for this paper.  
Program:           Antimicrobial Stewardship                        Situation: Need for universal program employed by Public health leadership as guidance for                         
appropriate antimicrobial usage based upon antimicrobial resistance patterns 
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Understanding of 
why the program 
exists and its 
benefits 
Improved patient 
outcomes 
Decrease in cost  
Timely laboratory 
data on current 
trends 
Assumptions: 
Funding and personnel are available at the government level so that 
the program can be a government run program.  Territory sizes will 
be dependent on resistance patterns for a region 
 
External Factors: Resistance patterns vary from community to 
community.  
Community use of antimicrobials  
Compliance from 
healthcare providers 
Decreased overall 
cost of healthcare 
for infectious 
disease 
Support from 
hospital 
administrators and 
policy makers 
 Decreased 
antimicrobial 
resistance 
 Increased 
microbial 
susceptibility  
 Decreased 
morbidity and 
mortality from 
infectious disease 
 
Antimicrobial 
cycling 
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Conclusion 
Antimicrobial resistance‟s impact on mankind is yet to be truly determined. It is known that in 
times prior to the use of antibiotics and the understanding of hygiene, infectious disease was the 
number one killer (Centers for Disease Control and Prevention (CDC), 2011).  We appear to be 
moving backwards to a time before antibiotics were developed. 
 Public health leaders have played an essential and influential role in the dramatic decline of 
mortality from infectious diseases in the past century and more, and should be called upon now 
to do the same. Many challenges still face the public health sector but proven successful public 
health initiatives, such as tobacco regulation, seatbelt safety, clean air acts and sanitation have 
shown that it is possible for public health to lead our nation towards a resolution (IOM (Institute 
of Medicine), 2011). The scope of AR is enormous and therefore, revisions to public health 
policy and statutes will most certainly require revision providing public health leader‟s authority 
over antimicrobial use. Healthcare institutions will need to follow such mandates to gain better 
control over this evolving issue.   
Many local, government and worldwide public and health organizations have identified AR as an 
increasing global threat for a number of years.  Each entity has made recommendations and has 
devised efforts to address the problem but somehow we remain unable to adequately apply 
solutions.  One approach is the requirement for ASPs. Although national guidance for such 
programs has been provided, too many variables have been left up to interpretation and too much 
leeway has been given in the development of programs. This is the greatest challenge before us 
as we move towards a concrete solution.  Although public health practitioners are more than 
capable of coordinating and policing a set of universal antimicrobial stewardship programs, they 
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will require assistance and collaboration from other health care professionals to create 
comprehensive and effective programs.  Additionally, funding and resources need to be directed 
towards preventive efforts (Centers for Disease Control and Prevention (CDC), 2011; Infectious 
Diseases Society of America (IDSA) et al., 2011; IOM (Institute of Medicine), 2011; World 
Health Organization, 2011).  
We should recognize where that 80% of the increase of life expectancy and quality in our 
populations during the 20
th
 Century has been as a result of the public health practices of disease 
prevention, promotion of healthy behaviors and protection against health risks (Centers for 
Disease Control and Prevention (CDC), 1999). We should institutionally provide the support 
necessary to maintain those amazing, achievements! 
  
 
 
 
 
 
 
 
- 
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